Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Takes Exclusive License to GenWay Biotech s Microbeads

NEW YORK, March 31 (GenomeWeb News) - Beckman Coulter has obtained an exclusive license to microbead technology made by San Diego-based GenWay Biotech, the companies announced today.

 

Under the terms of the agreement, GenWay will provide Beckman with access to its IgY microbead technology, which can be used to selectively partition the most abundant proteins from human serum or plasma in sample preparation for proteomics applications.

 

Financial details of the deal were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.